Abstract
Use of H3K9me3 modulation for enhancing cognitive function and treating anxiety related disorders is presented. A composition is administered to the subject comprising a therapeutically effective amount of a SUV39H1 inhibitor comprising analogs of ETP69. The therapeutically effective amount is effective in treating cognitive dysfunction in aging and age-related disorders.
Full Text
What is claimed is:
Use of H3K9me3 modulation for enhancing cognitive function and treating anxiety related disorders is presented. A composition is administered to the subject comprising a therapeutically effective amount of a SUV39H1 inhibitor comprising analogs of ETP69. The therapeutically effective amount is effective in treating cognitive dysfunction in aging and age-related disorders.
Timeline
Filed
04/11/2026Published
08/13/2026Granted
Not AvailableIPC Codes(11)
A61K 31/548:having two or more sulfur atoms in the same ring
A61K 31/202:having three or more double bonds, e.g. linolenic acid (eicosanoids, e.g. leukotrienes, A61K 31/557)
A61K 31/27:of carbamic or thiocarbamic acids, e.g. meprobamate, carbachol, neostigmine